Regulatory Communications and Submissions

Due to the growing interest in marketing new products, it is pivotal to establish a superior level of medical writing and regulatory operations. Executives within these roles need to create and manage successful submissions, as well as streamline timelines, to accelerate approval.

Attending the Optimizing Regulatory Communications and Submissions conference will aid delegates in expediting the approval of drugs while meeting requirements for different regulatory agencies worldwide. In addition, attendees will overcome key operational challenges impacting the approval process to enhance the quality of submissions.

  • Global guidelines for the development of biologics
  • Trends in designing chemistry, manufacturing and controls (CMC) components of regulatory submissions
  • Current Trends in Planning, Preparation and Delivering Regulatory Submissions
  • FDA CDER and CBER review
  • Speed Biologics development
  • Global trend for Biologics
  • Regulating regenerative medicine
  • Cosmetics
  • CTD, eCTD

Related Conference of Regulatory Communications and Submissions

June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Baltimore, Maryland, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
August 15-17, 2018

8th World Congress Spectroscopy and Analytical Techniques

Stockholm, Sweden
September 18-19, 2018

6th European Biopharma Congress

Amsterdam, Netherlands

Regulatory Communications and Submissions Conference Speakers

Recommended Sessions

Related Journals

Are you interested in